Approval · Notice of Compliance 58 · 2004
MIGRANAL: Notice of Compliance 58
Issued March 3, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 58
- Date
- March 3, 2004
- Company
- Sterimax Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- 5-ht1 receptor agonist, migraine therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIGRANAL | 02228947 | Marketed |
Medicinal ingredients
- DIHYDROERGOTAMINE MESYLATE 4 MG per ML